Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive

Use of immune checkpoint inhibitors (ICIs), a revolutionary treatment in modern oncology, is frequently complicated by immune-related adverse events (irAEs), which can be confused with infections, and vice versa, thus complicating management decisions. In this study, we review the published cases of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gudiol, Carlota, Hicklen, Rachel S, Okhyusen, Pablo C, Malek, Alexandre E, Kontoyiannis, Dimitrios P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679804/
https://www.ncbi.nlm.nih.gov/pubmed/36420059
http://dx.doi.org/10.1093/ofid/ofac570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679804/
https://www.ncbi.nlm.nih.gov/pubmed/36420059
http://dx.doi.org/10.1093/ofid/ofac570

Ejemplares similares